LOADING
Comparing Johnson & Johnson (JNJ) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | NKE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $554.7B | $62.8B |
| P/E Ratio | 26.0 | 27.9 |
| Forward P/E | 19.1 | 22.7 |
| PEG Ratio | 2.88 | 1.36 |
| EPS | $8.87 | $1.52 |
| Revenue Growth (YoY) | 9.9% | 0.1% |
| Profit Margin | 21.8% | 4.8% |
| Return on Equity | 26.4% | 16.0% |
| Dividend Yield | 2.32% | 3.67% |
| Beta | 0.26 | 1.12 |
| 52-Week High | $251.71 | $78.71 |
| 52-Week Low | $143.34 | $41.70 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Nike Inc offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.